| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 04/30/2014 | CN103763924A Cycloalkyl-fused tetrahydroquinolines as CRTH2 receptor modulators |
| 04/30/2014 | CN103755633A 8-aminoquinoline zinc perchlorate metal complex, and preparation method and application thereof |
| 04/30/2014 | CN103755632A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 04/30/2014 | CN103751119A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 04/30/2014 | CN103751118A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 04/30/2014 | CN102898367B Preparation method of pitavastatin calcium crude drug midbody |
| 04/30/2014 | CN102153498B Resveratrol analogue and preparation method and application thereof |
| 04/30/2014 | CN101668742B Bridged six-membered ring compounds |
| 04/29/2014 | US8710234 Amide derivatives, process for preparation thereof and use thereof as insecticide |
| 04/29/2014 | US8710230 Inhibitors of human immunodeficiency virus replication |
| 04/29/2014 | US8710229 Hepatitis C virus inhibitors |
| 04/29/2014 | US8710079 Quinoline compounds and their use for treating viral infection |
| 04/24/2014 | WO2014061647A1 Prenyloxyquinoline carboxylic-acid derivative |
| 04/24/2014 | US20140114075 Process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-n-methyl-1-naphthamide and synthetic intermediates thereof |
| 04/24/2014 | US20140114071 Process for the preparation of anhydrous aripiprazole crystal form ii |
| 04/24/2014 | US20140113934 Heterocyclic compounds for treating helminth infections |
| 04/24/2014 | US20140113012 Compounds and methods for inducing chondrogenesis |
| 04/24/2014 | US20140112946 Deuterium-enriched 4-hydroxy-5-methoxy-n,1-dimethyl-2-oxo-n-[(4-trifluoro-methyl)phenyl]-1,2-dihydroquinoline-3-carboxamide |
| 04/23/2014 | EP2721006A1 Heterocyclic compounds for treating helminth infections |
| 04/23/2014 | EP2720545A1 Cycloalkyl-fused tetrahydroquinolines as crth2 receptor modulators |
| 04/23/2014 | CN1997278B Substituted organosulfur compounds and methods of using thereof |
| 04/23/2014 | CN103739547A Synthesis method of 2-[6-methoxy-3-(2,3-dichlorophenyl)methyl-4-oxo-1,4-dihydro-1(4H)-quinolyl] acetic acid |
| 04/23/2014 | CN101723893B 2,3-disubstituted-2,3-dihydro quinoline ketone chiral compound as well as preparation method and application thereof |
| 04/22/2014 | US8703956 Amorphous (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid |
| 04/22/2014 | US8703949 Tandem process for preparing N-alkyl morphinans |
| 04/22/2014 | US8703803 Tris-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors |
| 04/22/2014 | US8703798 Antifungal and antiparasitic indoloquinoline derivatives |
| 04/22/2014 | US8703797 Condensed ring pyridine compounds as subtype-selective modulators of sphingosine-1-phosphate-2 (S1P2) receptors |
| 04/22/2014 | US8703773 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 04/22/2014 | US8703196 Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymers |
| 04/17/2014 | WO2014057874A1 Fluoranthene derivative, luminescent element material containing same, and luminescent element |
| 04/17/2014 | WO2014056465A1 An improved production method and new intermediates of synthesis of elvitegravir |
| 04/17/2014 | WO2014056464A1 A new production method and new intermediates of synthesis of elvitegravir |
| 04/17/2014 | US20140107156 Novel Amino Azaheterocyclic Carboxamides |
| 04/17/2014 | US20140107155 Substituted heterocyclic compounds as ion channel modulators |
| 04/17/2014 | US20140107153 Therapeutic quinoline and naphthalene derivatives |
| 04/17/2014 | US20140107143 Quaternary opioid carboxamides |
| 04/17/2014 | US20140107129 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics |
| 04/17/2014 | US20140107119 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| 04/17/2014 | US20140107074 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| 04/16/2014 | EP2718268A2 Novel process for the synthesis of 7-chloro-4-(piperazin-1-yl)-quinoline |
| 04/16/2014 | CN103732578A Quinolinyl glucagon receptor modulators |
| 04/16/2014 | CN103724349A Compound for treating cerebral palsy and use thereof |
| 04/16/2014 | CN103724344A Method for synthesizing nitrogen-containing heterocyclic compound |
| 04/16/2014 | CN103724262A Fluoroquinolonesilver compound as well as preparation method and application thereof |
| 04/16/2014 | CN103724261A Novel industrial production method for hydroxychloroquine sulfate |
| 04/16/2014 | CN103724260A Benzamide derivative and preparation method and application thereof |
| 04/16/2014 | CN102924374B Preparation method for quinoline-4-carboxylic acid derivative |
| 04/16/2014 | CN102766061B Dehydroabietic acid base diarylamine compound, synthesis method and application thereof |
| 04/16/2014 | CN102731329B Preparation method of cyclopropane derivative |
| 04/16/2014 | CN102574835B Compounds useful for treating cancer |
| 04/16/2014 | CN102224140B Curable composition comprising a thermolatent base |
| 04/15/2014 | US8697875 Phosphodiesterase inhibitors and uses thereof |
| 04/15/2014 | US8697739 Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof |
| 04/15/2014 | US8697725 Tetrahydroquinoline derivatives and their pharmaceutical use |
| 04/15/2014 | US8697724 Crystalline oxalate salts of a diamide compound |
| 04/15/2014 | US8697720 Substituted phenylether-thienopyridone compounds with antibacterial activity |
| 04/15/2014 | CA2786089C Nitrogen-containing heterocyclic compound and agricultural fungicide |
| 04/10/2014 | WO2014055603A1 Process for the preparation of an hiv integrase inhibitor |
| 04/10/2014 | WO2014054596A1 Organic electroluminescent element, organic el lighting and organic el display device |
| 04/10/2014 | WO2014053694A1 N-prop-2-ynyl carboxamide derivatives and their use as trpa1 antagonists |
| 04/10/2014 | WO2014053315A1 Tetrahydroquinoline derivatives and their use as epac inhibitors |
| 04/10/2014 | US20140100195 Heterobicyclic sphingosine 1-phosphate analogs |
| 04/09/2014 | CN103709100A Preparation method of 8-chloroquinolone derivatives |
| 04/09/2014 | CN103709072A Optically active trifluoromethyl amine compound and preparation method thereof |
| 04/09/2014 | CN103706399A Cyclometallated iridium catalyst for reducing nitrogen heterocyclic compounds under mild conditions |
| 04/09/2014 | CN102712596B Secondary 8-hydroxyquinoline-7-carboxamide derivatives |
| 04/09/2014 | CN102675201B Method for preparing 2-methyl-8-aminoquinoline from o-nitrophenol |
| 04/09/2014 | CN102675200B 2-phenyl-4-carbostyril compounds with antineoplastic activity, and preparation method and usage thereof |
| 04/09/2014 | CN102348691B Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenyiethoxy) hexyl]amino}-l- hydroxyethyl)-8-hydroxyquinolin-2(1h)-one. |
| 04/09/2014 | CN102026961B 酰胺化合物 Amide compounds |
| 04/09/2014 | CN101443314B Aminoquinolones as GSK-3 inhibitors |
| 04/09/2014 | CN101263119B 1,2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 04/08/2014 | US8691992 Octahydro biquinoline compound |
| 04/08/2014 | US8691986 Azetidine and piperidine compounds useful as PDE10 inhibitors |
| 04/08/2014 | US8691844 Method for treating thrombosis and inhibiting platelet aggregation with 21-(S)-argatroban |
| 04/08/2014 | US8691815 Substituted oxindole derivatives, drugs containing said derivatives and the use thereof |
| 04/03/2014 | WO2014048165A1 Compound as potassium channel modulator |
| 04/03/2014 | US20140094610 Process for the preparation of an hiv integrase inhibitor |
| 04/03/2014 | US20140094609 Process for the preparation of an hiv integrase inhibitor |
| 04/03/2014 | US20140094490 Anti-neurodegenerative disease agent |
| 04/03/2014 | US20140094465 Compounds as S-Nitrosoglutathione Reductase Inhibitors |
| 04/03/2014 | US20140094460 Fused heterocyclic compounds as ion channel modulators |
| 04/02/2014 | CN103694277A Red-phosphorescence organic light emitting diode (LED) |
| 04/02/2014 | CN103694169A Method for synthesis of 2,2,4-trimethyl-1,2-dihydroquinoline and polymer thereof by utilizing microchannel reactors |
| 04/02/2014 | CN103694163A Compounds capable of being adopted as potassium channel modulators |
| 04/02/2014 | CN102285915B Synthesis method for alkaloid secondary metabolite aspernigerin having anticancer activity |
| 04/01/2014 | US8686151 Montelukast 4-halobenzylamine salt and method for preparing montelukast sodium salt by using the same |
| 04/01/2014 | US8686002 Heterocyclic compounds and their use as binding partners for 5-HT5 receptors |
| 04/01/2014 | US8685971 Quinolinyloxyphenylsulfonamides |
| 04/01/2014 | US8685963 Compounds that inhibit NFκB and BACE1 activity |
| 04/01/2014 | US8685955 Neuroprotective iron chelators and pharmaceutical compositions comprising them |
| 03/27/2014 | WO2014044642A1 N-cyclopropylmethyl-2-(quinolin-6-yloxy)-acetamide derivatives and their use as fungicides |
| 03/27/2014 | WO2014044615A1 Dihydroquinolinone derivatives |
| 03/27/2014 | WO2014044566A1 Methods for the preparation of indacaterol and pharmaceutically acceptable salts thereof |
| 03/27/2014 | WO2014044288A1 Methods for the preparation of indacaterol and pharmaceutically acceptable salts thereof |
| 03/27/2014 | US20140088142 Modulators of cystic fibrosis transmembrane conductance regulator |
| 03/27/2014 | US20140088116 Novel Solid Forms of Antibiotics |
| 03/27/2014 | US20140088115 Pharmaceutical compositions having improved storage stability |
| 03/27/2014 | US20140088104 Novel small-molecules as therapeutics |